Prytime Medical, The REBOA Company™ , proudly announces the first civilian use of its pREBOA-PRO™ catheter in the European Union, following the device's receipt of CE Mark approval.

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the U.S. Food and Drug Administration ...

Real-world data from the largest U.S. Lyme disease registry, MyLymeData, shows current clinical trials for persistent Lyme disease (PLD) systematically exclude most patients who are clinically ...

Smoking is a significant risk factor for gum disease, tooth decay and oral cancer. Diabetic patients should quit smoking as ...

Learn how AI, blockchain, and IoT are transforming health insurance, improving efficiency, personalizing customer experiences ...

BIA 28-6156 is a first-in-class, small molecule for once-daily oral administration, allosteric activator of beta-glucocerebrosidase (GCase), in development for the treatment of pa ...

Explore healthcare trends, quizzes, tips, web stories, and medical humor in our weekly newsletter, Issue No.103 ...

By applying brief, localised pulses of magnetic fields, the team demonstrated a significant increase in the uptake of doxorubicin (DOX), a widely used chemotherapy drug, into brea ...

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer announced today that the first ...

Michigan's largest suicide prevention conference gathers leading experts to share advancements in suicide research, treatment, and prevention strategies GROSSE POINTE FARMS, Mich.

PreEvnt is a non-invasive alert device and custom phone app for monitoring an individual's blood glucose levels using just their breath. isaac reduces the need for, or fr ...

Lumia Health™ is debuting the world's first wearable that tracks blood flow to the head at CES 2025 (January 7-10) in Eureka Park, Venetian ...